戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 0.14; 95% CI, 0.07-0.27; reference category, obstetrics).
2 ibuted to increasing the usefulness of US in obstetrics.
3 tpartum recovery is an underexplored area of obstetrics.
4 ess a rounder inlet, which is beneficial for obstetrics.
5 de a summary of recent guidance on sepsis in obstetrics.
6 make it potentially very suitable for use in obstetrics.
7 erent hospitals and specialties: 18 (29%) in obstetrics, 16 (26%) in medicine, and 11 (18%) in each o
8 f International Federation of Gynecology and Obstetrics 2009 stage IA2 or IB1 squamous cell carcinoma
9 the most significant problem in contemporary obstetrics accounting for 5-18% of worldwide deliveries.
10 ess likely to report race and ethnicity than obstetrics (adjusted odds ratio [aOR], 0.54; 95% CI, 0.3
11 ents a significant challenge in reproductive obstetrics, affecting approximately 5% of couples global
12 m my perspective as a physician in high-risk obstetrics and 2019 American Diabetes Association Pathwa
13                                              Obstetrics and family planning demonstrated the most div
14                                              Obstetrics and family planning trials demonstrate improv
15 adult patients and relatives who visited the Obstetrics and Gynaecology and General Surgery Clinics o
16 ent of Anaesthesia, Surgery, Otolaryngology, Obstetrics and Gynaecology and Ophthalmology) and geogra
17 scrub nurses were randomly selected from the Obstetrics and Gynaecology Department of a teaching hosp
18 e at the respective health facilities in the Obstetrics and Gynaecology Department of Lagos State Uni
19 tedly healthy term new-born infants from the Obstetrics and Gynaecology ward at Hospital Kuala Lumpur
20  management in the perioperative period, and obstetrics and gynaecology.
21 White participants) who practiced in general obstetrics and gynecology (39 [72%]), maternal-fetal med
22 surgery (AOR, 2.05 [95% CI, 1.62-2.58]), and obstetrics and gynecology (AOR, 1.64 [95% CI, 1.24-2.15]
23 (n=3 each); surgical centers, fertility, and obstetrics and gynecology (n=2 each); and anesthesia, ho
24         Clinical trials guide evidence-based obstetrics and gynecology (OB-GYN) but often enroll nonr
25           Unlike other surgical specialties, obstetrics and gynecology (OB-GYN) has been predominantl
26  depression screening in general practice in obstetrics and gynecology (OB/GYN) clinics.
27 of females, particularly those in outpatient obstetrics and gynecology (OB/GYN) settings.
28  affect the training of approximately 44% of obstetrics and gynecology (OBGYN) residents in the US.
29 y examines racial and ethnic diversity among obstetrics and gynecology (OBGYN), surgical, and nonsurg
30 medicine and rehabilitation (SRQ, 1.60), and obstetrics and gynecology (SRQ, 1.47).
31 s), and the Council on Resident Education in Obstetrics and Gynecology (to program directors).
32 nternal medicine [IM], family medicine [FM], obstetrics and gynecology [OBGYN]) and 3 largest surgica
33 ly transmitted disease, family planning, and obstetrics and gynecology clinics.
34 imary specialty germane to the substudy (ie, obstetrics and gynecology for substudies 1 and 3 and pul
35 e recommendations of the American College of Obstetrics and Gynecology for women treated with tamoxif
36 or survival benefit, the American College of Obstetrics and Gynecology has recommendations for referr
37                                              Obstetrics and gynecology may present a different patter
38 ctive study carried out in the Department of Obstetrics and Gynecology Ramon y Cajal University Hospi
39 blished CE-OOC may become a powerful tool in obstetrics and gynecology research such as in studying c
40              The prevalence of this model in obstetrics and gynecology residencies is unknown.
41  obstetrics and gynecology residents and 293 obstetrics and gynecology residency program directors in
42 was prevalence of payer-based segregation in obstetrics and gynecology residency programs in the US a
43 rs, payer-based segregation was prevalent in obstetrics and gynecology residency programs, particular
44 This national survey study included all 6060 obstetrics and gynecology residents and 293 obstetrics a
45 ndent demographics reflected demographics of obstetrics and gynecology residents nationally in terms
46 03 patients with International Federation of Obstetrics and Gynecology stage III (n = 172) or IV (n =
47                                              Obstetrics and gynecology training programs can be ranke
48 ams (internal medicine, family medicine, and obstetrics and gynecology) and patient survey data were
49 tments were negative (anesthesiology, -1.1%; obstetrics and gynecology, -0.5%; radiology, -0.4%; and
50 l medicine and subspecialties, 2 (6.9%) from obstetrics and gynecology, 3 (10.3%) family medicine, 2
51  GME in specialties such as general surgery, obstetrics and gynecology, and emergency medicine has in
52 specialties of psychiatry, child psychiatry, obstetrics and gynecology, and family and general practi
53 osurgery, radiology, cardiovascular surgery, obstetrics and gynecology, and general surgery.
54 armacy, telephone calls to the department of obstetrics and gynecology, and prenatal visits with phys
55 (ophthalmology, otalaryngology, dermatology, obstetrics and gynecology, and surgery).
56 , endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized expe
57 ls in general medicine, pediatrics, surgery, obstetrics and gynecology, cancer, cardiovascular diseas
58 ans from family medicine, internal medicine, obstetrics and gynecology, cardiology, pulmonary, and on
59 , even female-dominated specialties, such as obstetrics and gynecology, have substantial inequity in
60                           In comparison with obstetrics and gynecology, IDSA guideline-concordant tre
61 control group, born at the 1st Department of Obstetrics and Gynecology, Medical University of Warsaw,
62 ry and 5 surgical specialties (neurosurgery, obstetrics and gynecology, ophthalmology, orthopedics, a
63 geons across multiple specialties, including obstetrics and gynecology, otolaryngology, and orthopedi
64 logy, emergency medicine, internal medicine, obstetrics and gynecology, pediatrics, and surgery.
65 general and plastic surgery, otolaryngology, obstetrics and gynecology, physical medicine, hematology
66 ialties (internal medicine, family practice, obstetrics and gynecology, surgery, pediatrics, and psyc
67 y PR peer review databases were searched for obstetrics and gynecology-related keywords.
68  women surgeons is increasing, especially in obstetrics and gynecology.
69 etrics, and Council on Resident Education in Obstetrics and Gynecology.
70 ize the national prevalence of this model in obstetrics and gynecology.
71 ency medicine and lower rates in urology and obstetrics and gynecology.
72 he Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intr
73                          Despite advances in obstetrics and neonatology, the rate of premature delive
74 logic outcomes of women participating in the Obstetrics and Periodontal Therapy (OPT) Study.
75  in secondary analyses of publicly available Obstetrics and Periodontal Therapy (OPT) trial data.
76                     A recent clinical trial (Obstetrics and Periodontal Therapy [OPT] Study) demonstr
77  MRI is increasingly implemented in clinical obstetrics and research.
78  (2) hematology, (3) maternal-fetal medicine/obstetrics, and (4) neonatology.
79 sciplinary collaboration between hematology, obstetrics, and anesthesia and shared decision-making wi
80  Association of Professors of Gynecology and Obstetrics, and Council on Resident Education in Obstetr
81 cine, hematology, oncology, transplantation, obstetrics, and immunology, among other areas, are neede
82 es in the management of sickle cell disease, obstetrics, and neonatal medicine, pregnancies complicat
83 o outpatient psychiatry as well as oncology, obstetrics, and primary care.
84 of pregnancy complications: a mouse model of obstetrics antiphospholipid syndrome (APS) and a mouse m
85 es were more commonly accepted, particularly obstetrics (aOR, 5.28; 95% CI, 4.17-6.70), STEMI (aOR, 3
86 tives of national pediatric, gynecology, and obstetrics associations, national immunization technical
87 commercial equipment, that its usefulness in obstetrics began to be realized fully by radiologists an
88 or at a tertian-care center with a high-risk obstetrics/cardiology clinic and 66 individually selecte
89 (International Federation of Gynaecology and Obstetrics) classification for the staging of endometria
90 cruited from University of Colorado Hospital obstetrics clinics in Aurora, Colorado.
91 uch methods are of great significance to the obstetrics community because of their potential use as c
92 re operative blood loss is expected (surgery/obstetrics) compared with those where blood loss is not
93                                              Obstetrics complications and excessive bleeding during d
94 nd transplants; COVID-19; ICU stays; sepsis; obstetrics; diabetes; and coagulopathies like hemophilia
95 ve scientific statements from cardiology and obstetrics experts guide the treatment of cardio-obstetr
96 rasound Doppler, Cardiac, Heart, Congenital, Obstetrics, Fetus Supplemental material is available for
97  International Federation of Gynaecology and Obstetrics (FIGO) 2009 stage I, endometrioid grade 3 can
98 9 International Federation of Gynecology and Obstetrics (FIGO) criteria (91.7%), that had squamous-ce
99 r International Federation of Gynecology and Obstetrics (FIGO) grade (P < .0001).
100 h International Federation of Gynecology and Obstetrics (FIGO) high-risk stage I-IV epithelial ovaria
101  International Federation of Gynaecology and Obstetrics (FIGO) risk score of 5 or 6 usually receive n
102 d International Federation of Gynecology and Obstetrics (FIGO) score was 0-4 in 33.3%, 5-6 in 46.7%,
103 , International Federation of Gynecology and Obstetrics (FIGO) stage distribution, and methodologic q
104 e International Federation of Gynecology and Obstetrics (FIGO) stage I (including borderline), two st
105  [International Federation of Gynecology and Obstetrics (FIGO) stage I/II of non-endometrioid histolo
106  International Federation of Gynaecology and Obstetrics (FIGO) stage IA1 with lymphovascular space in
107 h International Federation of Gynecology and Obstetrics (FIGO) stage IB to IV cervical cancer between
108 e International Federation of Gynecology and Obstetrics (FIGO) stage IB-IVA disease or FIGO stage IVB
109 n International Federation of Gynecology and Obstetrics (FIGO) stage IB3 squamous cell carcinoma of t
110 n International Federation of Gynecology and Obstetrics (FIGO) stage IC-IV epithelial ovarian cancer
111 d International Federation of Gynecology and Obstetrics (FIGO) stage II endometrial cancer: a 12-cm g
112 d International Federation of Gynecology and Obstetrics (FIGO) stage III to IV epithelial ovarian, pr
113 e International Federation of Gynecology and Obstetrics (FIGO) stage of ECs, respectively.
114 g International Federation of Gynecology and Obstetrics (FIGO) stage.
115 , International Federation of Gynecology and Obstetrics (FIGO) stages IIB through IVA, when lesions a
116 d International Federation of Gynecology and Obstetrics (FIGO) staging system for uterine cancer.
117  International Federation of Gynaecology and Obstetrics (FIGO) staging system was published, aiming t
118 d International Federation of Gynecology and Obstetrics (FIGO; 1988) stage IC-IIA high-grade serous,
119  (International Federation of Gynecology and Obstetrics [FIGO] stage I-IIa, grade 3 or clear cell his
120  (International Federation of Gynecology and Obstetrics [FIGO] stage III), for which the standard of
121 siologists in a variety of circumstances: in obstetrics for labor and emergencies, in trauma for emer
122  Fowler position, widely used in surgery and obstetrics for patient placement, marks a fraction of 19
123             A crucial contrast distinguishes obstetrics from cardiology and nephrology.
124 s in haematology, primary care, paediatrics, obstetrics, gastroenterology, cancer, and patient advoca
125 a International Federation of Gynecology and Obstetrics grade 3, uterine serous carcinoma, or carcino
126 , International Federation of Gynecology and Obstetrics grade, or adjuvant treatment.
127 tern Med), the Annals of Surgery (Ann Surg), Obstetrics & Gynecology (Obstet Gynecol), and the Journa
128 ication in Radiology and American Journal of Obstetrics & Gynecology.
129             The authors evaluated whether an obstetrics-gynecology clinic-based collaborative depress
130 seeking care in the general medical care and obstetrics-gynecology clinics of an urban public hospita
131 om 787 female patients attending one of four obstetrics-gynecology clinics.
132 November 2010 among postgraduate trainees in obstetrics-gynecology in 7 LMICs (Argentina, Brazil, Dem
133     Collaborative depression care adapted to obstetrics-gynecology settings had a greater impact on d
134 teen studies looked at general surgery, 6 at obstetrics-gynecology, 2 at urology, and 1 at otolaryngo
135 ar to be inclusive, because family medicine, obstetrics-gynecology, orthopedic surgery, and neurology
136 se exposures, 82% occurred on four services: obstetrics-gynecology, surgery, medicine, and emergency
137 taking internal medicine first compared with obstetrics/gynecology (mean difference, 0.65; 95% CI, 0.
138                             Family planning, obstetrics/gynecology (OB/GYN), or sexually transmitted
139 ernal medicine, family medicine, pediatrics, obstetrics/gynecology [OB/GYN] and 4 surgical specialtie
140 h-year medical students completing an 8-week obstetrics/gynecology clinical rotation, attendance at c
141                                The number of obstetrics/gynecology male graduates decreased 31.3%, wh
142 ear medical students who completed an 8-week obstetrics/gynecology rotation were included.
143 ase in debt (vs no debt), graduates choosing obstetrics/gynecology were less likely to be board certi
144 sistent recommendations varied by specialty (obstetrics/gynecology, 16.4%; internal medicine, 27.5%;
145 ernal medicine, 25.33 [95% CI, 25.07-25.60], obstetrics/gynecology, 24.68 [95% CI, 24.32-25.05], pedi
146 ernal medicine, 73.86 [95% CI, 73.33-74.39], obstetrics/gynecology, 72.36 [95% CI, 71.64-73.04], pedi
147 urology, orthopedic surgery, otolaryngology, obstetrics/gynecology, and ophthalmology clinics of the
148 hould be expanded to include antenatal care, obstetrics/gynecology, and targeted mass vaccination cam
149 l surgery, neurosurgery, orthopedic surgery, obstetrics/gynecology, emergency medicine, and radiology
150 ernal medicine, pediatrics, family practice, obstetrics/gynecology, general surgery, orthopedic surge
151 urgery, vascular surgery, pediatric surgery, obstetrics/gynecology, ophthalmology, and urology (n = 1
152                    Compared to clinicians in Obstetrics/Gynecology/Women's health, those in family me
153 to this, the emerging subspecialty of cardio-obstetrics has been growing over the past decade.
154                                       Cardio-obstetrics has emerged as an important multidisciplinary
155                      The specialty of cardio-obstetrics has emerged in response to the rising rates o
156                             Critical care in obstetrics has many similarities in pathophysiology to t
157 e International Federation of Gynecology and Obstetrics have produced standardized terminology and a
158     A substantial number of women treated in obstetrics have unrecognized and untreated psychiatric d
159 other-infant pairs were recruited at a large obstetrics hospital in Mexico City, Mexico, randomly ass
160  is not yet legalized in Japan, at least 153 obstetrics hospitals and 3320 clinics have closed.
161 aff and represented cardiovascular medicine, obstetrics, immunology, and pathology.
162 ssigned to US rotation, (b) the inclusion of obstetrics in US rotation, and (c) the opportunity for h
163 on-White and 16 [76.2%] White) who practiced obstetrics in Wisconsin.
164        Patients requiring pediatric surgery, obstetrics, interventional radiology, or endoscopic proc
165               The need to evaluate high-risk obstetrics is increasingly recognized.
166           The management of severe sepsis in obstetrics is multidisciplinary.
167                               A challenge in obstetrics is to distinguish pathological symptoms from
168 mands a multidisciplinary approach involving obstetrics, maternal-fetal medicine, and various surgica
169 ing, which involved international experts in obstetrics, midwifery, obstetric medicine, paediatrics,
170 6902 of 81 871 women (8.4%) with traditional obstetrics-model care (adjusted relative risks [aRR], 0.
171 with less postpartum ED use than traditional obstetrics-model care among women who had low risk and w
172 e between women with midwifery-model care vs obstetrics-model care, weighting by propensity score-bas
173 ed with 0 (0-1) visits among those receiving obstetrics-model care.
174                           Unlike traditional obstetrics models, the Ontario midwifery model offers ea
175 , or safety-net service lines (trauma, burn, obstetrics, neonatal intensive, and psychiatric care).
176                        A panel of experts in obstetrics, neonatology, paediatrics, laboratory and tra
177 cardiovascular risk and ensuring that cardio-obstetrics patients have access to the appropriate care
178     Because Medicare DRGs are unsuitable for obstetrics, pediatrics, and neonatology, some payers pre
179 g, bone marrow transplantation, ethics, law, obstetrics, pediatrics, and the social sciences were inv
180                          Patients undergoing obstetrics procedures or those who were intubated preope
181                                       Cardio-obstetrics refers to a team-based approach to maternal c
182 omized controlled trial was conducted at the obstetrics registration centers of 3 tertiary public hos
183  (International Federation of Gynecology and Obstetrics score >/= 7) gestational trophoblastic neopla
184 rienced hematologist/oncologist, a high-risk obstetrics specialist, a neonatologist, and experienced
185 eptance, considering prioritized conditions (obstetrics, ST-elevation myocardial infarction [STEMI],
186  (International Federation of Gynecology and Obstetrics stage 0 to IIIB).
187 y International Federation of Gynecology and Obstetrics stage I and low grade.
188 r International Federation of Gynecology and Obstetrics stage I or II carcinoma of the cervix were re
189 k International Federation of Gynecology and Obstetrics stage I or stage II to IV epithelial ovarian,
190 , International Federation of Gynecology and Obstetrics stage I-IV.
191 le and most had Federation of Gynecology and Obstetrics stage IB(1) and squamous cell carcinoma histo
192 h International Federation of Gynecology and Obstetrics stage IB1 cervical carcinoma who underwent at
193 h International Federation of Gynecology and Obstetrics stage IB2-IIb were randomly assigned between
194 h International Federation of Gynecology and Obstetrics stage Ic to IV disease to six cycles of docet
195 d International Federation of Gynecology and Obstetrics stage IC-IIA high-grade serous, clear cell, o
196 d International Federation of Gynecology and Obstetrics stage IC-IV epithelial ovarian cancer were ra
197 d International Federation of Gynecology and Obstetrics stage IC-IV ovarian cancer and an Eastern Coo
198 h International Federation of Gynecology and Obstetrics stage IIB to IV ovarian, fallopian tube, or p
199  (International Federation of Gynecology and Obstetrics stage IIB to IVA or with positive lymph nodes
200 f International Federation of Gynecology and Obstetrics stage III or IV epithelial ovarian cancer, bi
201 h International Federation of Gynecology and Obstetrics stage III or IV tumors received chemotherapy,
202  (International Federation of Gynecology and Obstetrics stage III or IV) who underwent first-line pla
203 h International Federation of Gynecology and Obstetrics stage III to IV ovarian cancer in complete cl
204 h International Federation of Gynecology and Obstetrics stage IV EOC who underwent primary surgery fo
205 y International Federation of Gynecology and Obstetrics stage) 9 or fewer months previously.
206 , International Federation of Gynecology and Obstetrics stage, tumor grade, pelvic node status, and t
207 d International Federation of Gynecology and Obstetrics stage.
208 r International Federation of Gynecology and Obstetrics stage.
209 y International Federation of Gynecology and Obstetrics stage/residual tumor.
210 l International Federation of Gynecology and Obstetrics stages IB2 (n = 79), IIA (n = 10), IIB (n = 1
211 d International Federation of Gynecology and Obstetrics stages II to IV or relapsed stage I epithelia
212  International Federation of Gynaecology and Obstetrics stages IIB, III, or IVA.
213  (International Federation of Gynecology and Obstetrics stages IIIC and IV) ovarian cancer.
214  (International Federation of Gynecology and Obstetrics) stages of EC were included, but patients wit
215 d International Federation of Gynecology and Obstetrics staging of gynecologic malignancies are also
216 8 International Federation of Gynecology and Obstetrics staging system for uterine cervical cancer.
217 e International Federation of Gynecology and Obstetrics staging system's stage, residual disease, his
218                  Outcome reporting in cardio-obstetrics studies is inconsistent.
219 resent outcomes) for inclusion in all cardio-obstetrics studies.
220 raged to measure and report in future cardio-obstetrics studies.
221 us and harmonize outcome reporting in cardio-obstetrics studies.
222 er, the current diagnostic tools in clinical obstetrics, such as Doppler ultrasound measurements of u
223                              Studies outside obstetrics suggest that postoperative morbidity and mort
224  identified patients evaluated by our cardio-obstetrics team from January 1, 2010, through December 3
225              Early involvement of the cardio-obstetrics team is critical to prevent maternal morbidit
226 n counseling by the multidisciplinary cardio-obstetrics team is essential for women with preexistent
227                   A multidisciplinary cardio-obstetrics team should ensure appropriate monitoring dur
228 d-insured pregnant women managed by a cardio-obstetrics team, maternal outcomes were encouraging and
229 ovascular disease (CVD) followed by a cardio-obstetrics team.
230 h opens new horizons for drug development in obstetrics that could greatly impact preterm birth, whic
231           Here we show for the first time in obstetrics the use of a targeted nanoparticle directed t
232 k-stratification tools are routinely used in obstetrics to assist care teams in assessing and communi
233  Association of Professors of Gynecology and Obstetrics (to clerkship directors), and the Council on
234 vides a blueprint on incorporation of cardio-obstetrics training into cardiovascular disease fellowsh
235 various disciplines (hematology, nephrology, obstetrics, transplantation, rheumatology, and neurology
236 used for large numbers of patients attending obstetrics units.
237 e (median) episiotomy has no place in modern obstetrics; when episiotomy must be performed for obstet
238 ere developed by the maternal-fetal medicine/obstetrics working group.

 
Page Top